165 related articles for article (PubMed ID: 35939608)
1. Comparison of Persistent Symptoms Following SARS-CoV-2 Infection by Antibody Status in Nonhospitalized Children and Adolescents.
Messiah SE; Hao T; DeSantis SM; Swartz MD; Talebi Y; Kohl HW; Zhang S; Valerio-Shewmaker M; Yaseen A; Kelder SH; Ross J; Gonzalez MO; Wu L; Padilla LN; Lopez KR; Lakey D; Shuford JA; Pont SJ; Boerwinkle E
Pediatr Infect Dis J; 2022 Oct; 41(10):e409-e417. PubMed ID: 35939608
[TBL] [Abstract][Full Text] [Related]
2. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.
; Wulf Hanson S; Abbafati C; Aerts JG; Al-Aly Z; Ashbaugh C; Ballouz T; Blyuss O; Bobkova P; Bonsel G; Borzakova S; Buonsenso D; Butnaru D; Carter A; Chu H; De Rose C; Diab MM; Ekbom E; El Tantawi M; Fomin V; Frithiof R; Gamirova A; Glybochko PV; Haagsma JA; Haghjooy Javanmard S; Hamilton EB; Harris G; Heijenbrok-Kal MH; Helbok R; Hellemons ME; Hillus D; Huijts SM; Hultström M; Jassat W; Kurth F; Larsson IM; Lipcsey M; Liu C; Loflin CD; Malinovschi A; Mao W; Mazankova L; McCulloch D; Menges D; Mohammadifard N; Munblit D; Nekliudov NA; Ogbuoji O; Osmanov IM; Peñalvo JL; Petersen MS; Puhan MA; Rahman M; Rass V; Reinig N; Ribbers GM; Ricchiuto A; Rubertsson S; Samitova E; Sarrafzadegan N; Shikhaleva A; Simpson KE; Sinatti D; Soriano JB; Spiridonova E; Steinbeis F; Svistunov AA; Valentini P; van de Water BJ; van den Berg-Emons R; Wallin E; Witzenrath M; Wu Y; Xu H; Zoller T; Adolph C; Albright J; Amlag JO; Aravkin AY; Bang-Jensen BL; Bisignano C; Castellano R; Castro E; Chakrabarti S; Collins JK; Dai X; Daoud F; Dapper C; Deen A; Duncan BB; Erickson M; Ewald SB; Ferrari AJ; Flaxman AD; Fullman N; Gamkrelidze A; Giles JR; Guo G; Hay SI; He J; Helak M; Hulland EN; Kereselidze M; Krohn KJ; Lazzar-Atwood A; Lindstrom A; Lozano R; Malta DC; Månsson J; Mantilla Herrera AM; Mokdad AH; Monasta L; Nomura S; Pasovic M; Pigott DM; Reiner RC; Reinke G; Ribeiro ALP; Santomauro DF; Sholokhov A; Spurlock EE; Walcott R; Walker A; Wiysonge CS; Zheng P; Bettger JP; Murray CJL; Vos T
JAMA; 2022 Oct; 328(16):1604-1615. PubMed ID: 36215063
[TBL] [Abstract][Full Text] [Related]
3. Strategies to Estimate Prevalence of SARS-CoV-2 Antibodies in a Texas Vulnerable Population: Results From Phase I of the Texas Coronavirus Antibody Response Survey.
Valerio-Shewmaker MA; DeSantis S; Swartz M; Yaseen A; Gonzalez MO; Kohl HWI; Kelder SH; Messiah SE; Aguillard KA; Breaux C; Wu L; Shuford J; Pont S; Lakey D; Boerwinkle E
Front Public Health; 2021; 9():753487. PubMed ID: 34970525
[No Abstract] [Full Text] [Related]
4. SARS-CoV-2 Serostatus and COVID-19 Illness Characteristics by Variant Time Period in Non-Hospitalized Children and Adolescents.
Messiah SE; Swartz MD; Abbas RA; Talebi Y; Kohl HW; Valerio-Shewmaker M; DeSantis SM; Yaseen A; Kelder SH; Ross JA; Padilla LN; Gonzalez MO; Wu L; Lakey D; Shuford JA; Pont SJ; Boerwinkle E
Children (Basel); 2023 Apr; 10(5):. PubMed ID: 37238366
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.
de Hoog MLA; Sluiter-Post JGC; Westerhof I; Fourie E; Heuvelman VD; Boom TT; Euser SM; Badoux P; Reusken C; Bont LJ; Sanders EAM; Jaddoe VWV; Herpers BL; Eggink D; Wildenbeest JG; Duijts L; van Houten MA; Bruijning-Verhagen PCJL
JAMA Netw Open; 2022 Oct; 5(10):e2237522. PubMed ID: 36264578
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Seroconversion in Children and Adults With Mild COVID-19.
Toh ZQ; Anderson J; Mazarakis N; Neeland M; Higgins RA; Rautenbacher K; Dohle K; Nguyen J; Overmars I; Donato C; Sarkar S; Clifford V; Daley A; Nicholson S; Mordant FL; Subbarao K; Burgner DP; Curtis N; Bines JE; McNab S; Steer AC; Mulholland K; Tosif S; Crawford NW; Pellicci DG; Do LAH; Licciardi PV
JAMA Netw Open; 2022 Mar; 5(3):e221313. PubMed ID: 35262717
[TBL] [Abstract][Full Text] [Related]
7. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Clinical and Virological Characteristics of SARS-CoV-2 Infection Among Children Aged 0 to 4 Years and Their Household Members.
Karron RA; Hetrich MK; Na YB; Knoll MD; Schappell E; Meece J; Hanson E; Tong S; Lee JS; Veguilla V; Dawood FS;
JAMA Netw Open; 2022 Aug; 5(8):e2227348. PubMed ID: 36044218
[TBL] [Abstract][Full Text] [Related]
9. Dynamic and features of SARS-CoV-2 infection in Gabon.
Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
[TBL] [Abstract][Full Text] [Related]
10. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study.
Haddad A; Janda A; Renk H; Stich M; Frieh P; Kaier K; Lohrmann F; Nieters A; Willems A; Huzly D; Dulovic A; Schneiderhan-Marra N; Jacobsen EM; Fabricius D; Zernickel M; Stamminger T; Bode SFN; Himpel T; Remppis J; Engel C; Peter A; Ganzenmueller T; Hoffmann GF; Haase B; Kräusslich HG; Müller B; Franz AR; Debatin KM; Tönshoff B; Henneke P; Elling R
EBioMedicine; 2022 Oct; 84():104245. PubMed ID: 36155957
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Symptoms and RNA Levels in Children and Adults With SARS-CoV-2 Infection in the Community Setting.
Chung E; Chow EJ; Wilcox NC; Burstein R; Brandstetter E; Han PD; Fay K; Pfau B; Adler A; Lacombe K; Lockwood CM; Uyeki TM; Shendure J; Duchin JS; Rieder MJ; Nickerson DA; Boeckh M; Famulare M; Hughes JP; Starita LM; Bedford T; Englund JA; Chu HY
JAMA Pediatr; 2021 Oct; 175(10):e212025. PubMed ID: 34115094
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection.
Gerhards C; Thiaucourt M; Kittel M; Becker C; Ast V; Hetjens M; Neumaier M; Haselmann V
Int J Infect Dis; 2021 Jun; 107():221-227. PubMed ID: 33932604
[TBL] [Abstract][Full Text] [Related]
13. Seroepidemiology of SARS-CoV-2 in pediatric population during a 16-month period prior to vaccination.
Filippatos F; Tatsi EB; Dellis C; Efthymiou V; Margeli A; Papassotiriou I; Syriopoulou V; Michos A
J Med Virol; 2022 May; 94(5):2174-2180. PubMed ID: 35064572
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of SARS-CoV-2 Antibodies in Children and Adults with Type 1 Diabetes.
Jia X; Gesualdo P; Geno Rasmussen C; Alkanani AA; He L; Dong F; Rewers MJ; Michels AW; Yu L
Diabetes Technol Ther; 2021 Jul; 23(7):517-521. PubMed ID: 33544017
[No Abstract] [Full Text] [Related]
15. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
16. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
[TBL] [Abstract][Full Text] [Related]
17. The seroprevalence of SARS-CoV-2 in a rural southwest community.
Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in Samples from Vaccinated Individuals.
Hayer J; Urlaub E
Microbiol Spectr; 2022 Jun; 10(3):e0270921. PubMed ID: 35575594
[TBL] [Abstract][Full Text] [Related]
19. Persistent Symptoms and Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection Not Requiring Hospitalization: Results From Testing Denmark, a Danish Cross-sectional Survey.
van Wijhe M; Fogh K; Ethelberg S; Karmark Iversen K; Nielsen H; Østergaard L; Andersen B; Bundgaard H; Jørgensen CS; Scharff BFS; Ellermann-Eriksen S; Johansen IS; Fomsgaard A; Grove Krause T; Wiese L; Fischer TK; Mølbak K; Benfield T; Folke F; Lippert F; Ostrowski SR; Koch A; Erikstrup C; Vangsted AM; Sørensen AIV; Ullum H; Skov RL; Simonsen L; Nielsen SD
Open Forum Infect Dis; 2023 Jan; 10(1):ofac679. PubMed ID: 36628054
[TBL] [Abstract][Full Text] [Related]
20. Serological evaluation of patients with coronavirus disease-2019 in Daegu, South Korea.
Park S; Chang SH; Lee JH; Lee JH; Ham JY; Kim YK; Kim SG; Ryoo NH
PLoS One; 2022; 17(1):e0262820. PubMed ID: 35051239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
